The systematic and indication-specific determination of autoantibody patterns will serve as a powerful basis to address hitherto unmet diagnostic needs. UNIarray serves as platform for the development of
The trial was designed to demonstrate survival benefit for patients treated with PHP after 28 days compared to placebo (+ standard care), and at day 60 and day
The company’s gross profit for the fourth quarter was $10.5m, an increase of 25.2% compared to $8.4m in 2009. Lotus Pharma‘s revenues for the fiscal year ended 31
Soren Stroh, founder and previous owner, continues his role as CEO of aCROnordic for Nordic region. aCROnordic is a provider of drug and medical device development services to
The company is constructing a new 60,000sqft building adjacent to existing buildings to create a Slough campus. Lonza‘s Slough site is into developing and manufacturing antibodies and therapeutic
Headquartered in New Jersey, JHP Pharma is a provider of contract manufacturing of sterile injectables, biologics, vaccines, ophthalmics and otics for large and small pharmaceutical and biotech organizations.
The payment triggers from the transferring of Alnylam‘s RNA interference drug technology to Takeda Pharma for the development of RNAi therapeutics. Earlier, Alnylam has obtained $140m in upfront
The Phase 1, open-label, randomised, clinical trial will be conducted at three clinical sites in Northern California, US. The study will enroll 40 postmenopausal women between the ages
The India-based company is close to completing the Phase I clinical trial of NRC-AN-019 in India, and is planning to conduct further clinical trials in the US and
Slimple contains MaCoca, a proprietary blend that is derived from Decocainized Coca Leaf, that burns more calories through a process konown as Thermogenesis. Slimple acts as a fat
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.